phorbol-12-myristate has been researched along with chlorogenic acid in 1 studies
Studies (phorbol-12-myristate) | Trials (phorbol-12-myristate) | Recent Studies (post-2010) (phorbol-12-myristate) | Studies (chlorogenic acid) | Trials (chlorogenic acid) | Recent Studies (post-2010) (chlorogenic acid) |
---|---|---|---|---|---|
128 | 0 | 79 | 3,276 | 76 | 2,241 |
Protein | Taxonomy | phorbol-12-myristate (IC50) | chlorogenic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 7.9 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.95 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 1.05 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.1 | |
large T antigen | Betapolyomavirus macacae | 14.67 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Karadeniz, F; Kil, JH; Kong, CS; Lee, JI; Oh, JH; Seo, Y; Yu, GH | 1 |
1 other study(ies) available for phorbol-12-myristate and chlorogenic acid
Article | Year |
---|---|
3,5-Dicaffeoyl-epi-quinic acid inhibits the PMA-stimulated activation and expression of MMP-9 but not MMP-2 via downregulation of MAPK pathway.
Topics: Atriplex; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Structure; Phorbol Esters; Plant Extracts; Quinic Acid | 2020 |